The resultant TRACP protein products were characterized in human cell lines to define the effects of the specific amino acid changes and provide direct evidence for the causal mechanism of TRACP deficiency in SPENCD patients. Here, ACP5 is linked to Spondyloenchondrodysplasia with immune dysregulation.